MCID: BLS005
MIFTS: 13

Blastema Predominant Kidney Wilms' Tumor

Categories: Cancer diseases, Nephrological diseases

Aliases & Classifications for Blastema Predominant Kidney Wilms' Tumor

MalaCards integrated aliases for Blastema Predominant Kidney Wilms' Tumor:

Name: Blastema Predominant Kidney Wilms' Tumor 12
Blastema Predominant Kidney Adenosarcoma 12
Blastema Predominant Renal Wilms Tumor 12
Blastema Predominant Wilms' Tumor 74

Classifications:



External Ids:

Disease Ontology 12 DOID:5182
NCIt 51 C9147
UMLS 74 C0279609

Summaries for Blastema Predominant Kidney Wilms' Tumor

MalaCards based summary : Blastema Predominant Kidney Wilms' Tumor, is also known as blastema predominant kidney adenosarcoma, and has symptoms including abdominal pain The drugs Carboplatin and Etoposide have been mentioned in the context of this disorder. Affiliated tissues include kidney.

Related Diseases for Blastema Predominant Kidney Wilms' Tumor

Symptoms & Phenotypes for Blastema Predominant Kidney Wilms' Tumor

UMLS symptoms related to Blastema Predominant Kidney Wilms' Tumor:


abdominal pain

Drugs & Therapeutics for Blastema Predominant Kidney Wilms' Tumor

Drugs for Blastema Predominant Kidney Wilms' Tumor (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 20)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Carboplatin Approved Phase 3 41575-94-4 10339178 38904 498142
2
Etoposide Approved Phase 3 33419-42-0 36462
3
Vincristine Approved, Investigational Phase 3 2068-78-2, 57-22-7 5978
4
Cyclophosphamide Approved, Investigational Phase 3 50-18-0, 6055-19-2 2907
5
Doxorubicin Approved, Investigational Phase 3 23214-92-8 31703
6
Dactinomycin Approved, Investigational Phase 3 50-76-0 457193 2019
7
Doxil Approved June 1999 Phase 3 31703
8 Immunologic Factors Phase 3
9 Topoisomerase Inhibitors Phase 3
10 Antimitotic Agents Phase 3
11 Antineoplastic Agents, Alkylating Phase 3
12 Etoposide phosphate Phase 3
13 Alkylating Agents Phase 3
14 Antineoplastic Agents, Phytogenic Phase 3
15 Antibiotics, Antitubercular Phase 3
16 Nucleic Acid Synthesis Inhibitors Phase 3
17 Anti-Bacterial Agents Phase 3
18 Immunosuppressive Agents Phase 3
19 Anti-Infective Agents Phase 3
20 Antirheumatic Agents Phase 3

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 Chemotherapy Before and After Surgery in Treating Children With Wilm's Tumor Unknown status NCT00047138 Phase 3 carboplatin;cyclophosphamide;doxorubicin hydrochloride;etoposide;vincristine sulfate

Search NIH Clinical Center for Blastema Predominant Kidney Wilms' Tumor

Genetic Tests for Blastema Predominant Kidney Wilms' Tumor

Anatomical Context for Blastema Predominant Kidney Wilms' Tumor

MalaCards organs/tissues related to Blastema Predominant Kidney Wilms' Tumor:

42
Kidney

Publications for Blastema Predominant Kidney Wilms' Tumor

Variations for Blastema Predominant Kidney Wilms' Tumor

Expression for Blastema Predominant Kidney Wilms' Tumor

Search GEO for disease gene expression data for Blastema Predominant Kidney Wilms' Tumor.

Pathways for Blastema Predominant Kidney Wilms' Tumor

GO Terms for Blastema Predominant Kidney Wilms' Tumor

Sources for Blastema Predominant Kidney Wilms' Tumor

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....